The Coronavirus Disease 2019 (COVID-19) has already caused hundreds of thousands of
deaths worldwide in a few months. Cardiovascular disease, hypertension, diabetes and …

The incidence of heart failure is primarily flat or declining for a presumably reflecting better
management of cardiovascular diseases, but that of heart failure with preserved ejection …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is still an ongoing global health crisis. Immediately after the …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) enters the host cell by
binding to angiotensin‐converting enzyme 2 (ACE2) receptor. Other important proteins …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the responsible agent for
the coronavirus disease 2019 (Covid-19), has its entry point through interaction with …

Men are disproportionately affected by the coronavirus disease-2019 (COVID-19), and face
higher odds of severe illness and death compared to women. The vascular effects of …

The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular
circulating hormonal system, it is now accepted as a local tissue system that works …

COVID-19 has shown significant morbidity with the involvement of multiple systems,
including the cardiovascular system. Cardiovascular manifestations in the acute phase can …

COVID‐19 is a complex disease, and many difficulties are faced today especially in the
proper choice of pharmacological treatments. The role of antiviral agents for COVID‐19 is …

Bridging systems biology and drug design, we propose a deep learning framework for de
novo discovery of molecules tailored to bind with given protein targets. Our methodology is …